Molecular interplay between endostatin, integrins, and heparan sulfate.
about
KSHV attachment and entry are dependent on αVβ3 integrin localized to specific cell surface microdomains and do not correlate with the presence of heparan sulfateExtended interaction network of procollagen C-proteinase enhancer-1 in the extracellular matrixThe first draft of the endostatin interaction networkComparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenanceMatricryptins Network with Matricellular Receptors at the Surface of Endothelial and Tumor CellsSynergistic antitumor effects of endostar in combination with oxaliplatin via inhibition of HIF and CXCR4 in the colorectal cell line SW1116Tetrastatin, the NC1 domain of the α4(IV) collagen chain: a novel potent anti-tumor matrikine.Heparin and liver heparan sulfate can rescue hepatoma cells from topotecan action.Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers.Lack of collagen XVIII long isoforms affects kidney podocytes, whereas the short form is needed in the proximal tubular basement membrane.Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling.Computational systems biology approaches to anti-angiogenic cancer therapeutics.Arterial Hypertension Is Characterized by Imbalance of Pro-Angiogenic versus Anti-Angiogenic FactorsThe anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction.A Novel Collagen Matricryptin Reduces Left Ventricular Dilation Post-Myocardial Infarction by Promoting Scar Formation and Angiogenesis.ANGPTL4-αvβ3 interaction counteracts hypoxia-induced vascular permeability by modulating Src signalling downstream of vascular endothelial growth factor receptor 2.Target-derived matricryptins organize cerebellar synapse formation through α3β1 integrins.Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney.Type XVIII collagen is essential for survival during acute liver injury in miceLarge-scale investigation of Leishmania interaction networks with host extracellular matrix by surface plasmon resonance imaging.Heparan sulfate in angiogenesis: a target for therapy.Matricryptins and matrikines: biologically active fragments of the extracellular matrix.Mapping of heparin/heparan sulfate binding sites on αvβ3 integrin by molecular docking.Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.Regulation of skeletal muscle capillary growth in exercise and disease.Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.Glycosaminoglycanomics: where we are.Sulfatase-mediated manipulation of the astrocyte-Schwann cell interface.Isolation, characterization and biological evaluation of jellyfish collagen for use in biomedical applications.Binding of procollagen C-proteinase enhancer-1 (PCPE-1) to heparin/heparan sulfate: properties and role in PCPE-1 interaction with cells.Abnormally High Content of Free Glucosamine Residues Identified in a Preparation of Commercially Available Porcine Intestinal Heparan Sulfate.Characterization of the interaction between endostatin short peptide and VEGF receptor 3.Transglutaminase-2: a new endostatin partner in the extracellular matrix of endothelial cells.Yersinia enterocolitica exploits different pathways to accomplish adhesion and toxin injection into host cells.Modulation of network activity and induction of homeostatic synaptic plasticity by enzymatic removal of heparan sulfates.Endostatin binds nerve growth factor and thereby inhibits neurite outgrowth and neuronal migration in-vitro.Structural analysis of the N-terminal fragment of the antiangiogenic protein endostatin: a molecular dynamics study.Modular GAG-matrices to promote mammary epithelial morphogenesis in vitro.EGFR activation triggers cellular hypertrophy and lysosomal disease in NAGLU-depleted cardiomyoblasts, mimicking the hallmarks of mucopolysaccharidosis IIIB.
P2860
Q24301376-BF82909D-C29F-4320-BADE-E0B9339A4332Q24338239-8E71FEC0-9AE4-42B0-AEFA-AB94013829FFQ24338820-F8E6F90E-D52B-4F22-8732-2CC7BF5CE84BQ24339581-D96B1295-6636-4D07-B454-B2680F10C81CQ26766481-2B3DB77F-AB31-46DC-9C80-5316E8E3FBFAQ28484315-C92CC298-D20F-4C10-82A5-8A9CC1065121Q31058993-F0D88008-769E-45DA-8849-44D81B95E296Q34222480-622DDE55-0877-4BC5-A69D-02E7C150953FQ34354606-50C5C6E2-57DA-474C-9975-5D7D2AB43943Q34624094-23AC31AA-093D-42A5-B519-C67027A3417EQ35001659-CEE34811-F6F3-4235-B6E0-090A5A7BAA35Q35108084-FA805355-9A7E-4877-B1F5-B9FD38BBF73CQ35581401-3FFD53EE-56FA-4234-B41E-0FE0A2CAC98EQ35856555-6202545A-4919-40B4-96C6-3E05620F54B5Q36073744-3F0AA40B-D16E-47FA-BCC3-C06D520F7BD4Q36117879-323F1114-44CE-4D1A-B209-F4469BE7B14DQ36205265-8E419482-2D1E-4948-A8EA-ADC56D47EBF7Q36220259-2C92343A-5DFE-46CD-AB93-3B75D259A580Q36905578-40B8A491-C73B-4960-89B8-18D50A6E32F1Q36981820-EF1B6394-905A-467A-AA1B-6DF142C5E64BQ37546467-FB99DB16-C40A-4C68-88A2-C3AE94737BDBQ38154506-F51E2CC6-D89A-44DB-8F29-FFADC76EDF4BQ38210749-51E4D039-60BB-4E1D-B4FE-270A692A93D9Q38318355-84541A14-8FD5-47D0-B09D-23754031F45FQ38418286-09903328-C063-4BA7-8C97-79BDD7086539Q38629583-86A9FA9B-D475-4904-B5F9-46BDD3436ED7Q38974266-52889380-3C79-4C7E-92D0-BFB1E9B62749Q39143849-07B2702F-0086-40CD-9495-2395241BFA81Q39479528-0D72CEA9-188F-4D59-B352-EA57A046933CQ39508574-AFEBD966-66F0-4B55-8E24-AC55645DC326Q39664721-AB32F05D-024B-41E9-B270-34A8266061B9Q39687869-8D8D4393-289D-4A75-81FD-B949BF067C39Q40474234-67A1019C-FA2D-45E6-A883-B0B17A44ED4EQ40760483-BB3B47D2-D30E-4C9F-9E54-5255B7EA7691Q41378728-B4749A6A-820F-41C3-94C2-89EBBFD1FAECQ42912435-A19E603F-E5BA-4D88-BA7F-EFF789EF58D2Q43042279-6363227D-84DD-492A-A9E4-FE21227A8CF9Q46157805-4F9F06B2-15F3-423E-A491-C26554255E5CQ47255365-6C8A7590-3F8B-4E2E-843B-D545E66BE50FQ47564454-2557194A-A7EE-451E-8A11-7AC61CC2B292
P2860
Molecular interplay between endostatin, integrins, and heparan sulfate.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular interplay between endostatin, integrins, and heparan sulfate.
@en
Molecular interplay between endostatin, integrins, and heparan sulfate.
@nl
type
label
Molecular interplay between endostatin, integrins, and heparan sulfate.
@en
Molecular interplay between endostatin, integrins, and heparan sulfate.
@nl
prefLabel
Molecular interplay between endostatin, integrins, and heparan sulfate.
@en
Molecular interplay between endostatin, integrins, and heparan sulfate.
@nl
P2093
P2860
P50
P356
P1476
Molecular interplay between endostatin, integrins, and heparan sulfate
@en
P2093
Bjorn R Olsen
Clément Faye
Florence Ruggiero
Naomi Fukai
Reidunn Jetne
Sylvie Ricard-Blum
P2860
P304
22029-22040
P356
10.1074/JBC.M109.002840
P407
P577
2009-06-05T00:00:00Z